Xr Securities LLC Relmada Therapeutics, Inc. Transaction History
Xr Securities LLC
- $0
- Q1 2025
A detailed history of Xr Securities LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Xr Securities LLC holds 16,400 shares of RLMD stock, worth $4,920. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,400Holding current value
$4,920% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding RLMD
# of Institutions
55Shares Held
8.32MCall Options Held
364KPut Options Held
46.5K-
Franklin Resources Inc San Mateo, CA1.3MShares$390,6450.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.26MShares$377,0110.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.23MShares$368,3780.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$171,9940.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA495KShares$148,5430.04% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $8.58M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...